Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Elbanovir vs Sovaldi (Sofosbuvir) in Healthy Volunteers
NCT02605798Phase 1Completed
- Sponsor
- Genuine Research Center
- Start
- Aug 2015
- Primary completion
- Sep 2015
- Modality
- Nucleic Acid-Directed Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sofosbuvir in hepatitis C (HCV) (3 arms), sponsored by Genuine Research Center. Primary endpoints: Maximal measured plasma concentration, Area under the plasma concentration-time curve from time zero to time t and 1 more. Started Aug 2015; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02605798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02605798.